280 related articles for article (PubMed ID: 15840648)
1. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP.
Hsiao VC; Tian R; Long H; Der Perng M; Brenner M; Quinlan RA; Goldman JE
J Cell Sci; 2005 May; 118(Pt 9):2057-65. PubMed ID: 15840648
[TBL] [Abstract][Full Text] [Related]
2. Mild functional effects of a novel GFAP mutant allele identified in a familial case of adult-onset Alexander disease.
Bachetti T; Caroli F; Bocca P; Prigione I; Balbi P; Biancheri R; Filocamo M; Mariotti C; Pareyson D; Ravazzolo R; Ceccherini I
Eur J Hum Genet; 2008 Apr; 16(4):462-70. PubMed ID: 18197187
[TBL] [Abstract][Full Text] [Related]
3. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.
Der Perng M; Su M; Wen SF; Li R; Gibbon T; Prescott AR; Brenner M; Quinlan RA
Am J Hum Genet; 2006 Aug; 79(2):197-213. PubMed ID: 16826512
[TBL] [Abstract][Full Text] [Related]
4. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
Tian R; Gregor M; Wiche G; Goldman JE
Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of curcumin on GFAP filament organization and down-regulation of GFAP expression in an in vitro model of Alexander disease.
Bachetti T; Di Zanni E; Balbi P; Ravazzolo R; Sechi G; Ceccherini I
Exp Cell Res; 2012 Sep; 318(15):1844-54. PubMed ID: 22705585
[TBL] [Abstract][Full Text] [Related]
6. Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition.
Tang G; Perng MD; Wilk S; Quinlan R; Goldman JE
J Biol Chem; 2010 Apr; 285(14):10527-37. PubMed ID: 20110364
[TBL] [Abstract][Full Text] [Related]
7. Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.
Chen YS; Lim SC; Chen MH; Quinlan RA; Perng MD
Exp Cell Res; 2011 Oct; 317(16):2252-66. PubMed ID: 21756903
[TBL] [Abstract][Full Text] [Related]
8. GFAP mutations in Alexander disease.
Li R; Messing A; Goldman JE; Brenner M
Int J Dev Neurosci; 2002; 20(3-5):259-68. PubMed ID: 12175861
[TBL] [Abstract][Full Text] [Related]
9. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
10. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease.
Sosunov AA; McKhann GM; Goldman JE
Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321
[TBL] [Abstract][Full Text] [Related]
11. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease.
Mignot C; Delarasse C; Escaich S; Della Gaspera B; Noé E; Colucci-Guyon E; Babinet C; Pekny M; Vicart P; Boespflug-Tanguy O; Dautigny A; Rodriguez D; Pham-Dinh D
Exp Cell Res; 2007 Aug; 313(13):2766-79. PubMed ID: 17604020
[TBL] [Abstract][Full Text] [Related]
13. Effects of Alexander disease-associated mutations on the assembly and organization of GFAP intermediate filaments.
Yang AW; Lin NH; Yeh TH; Snider N; Perng MD
Mol Biol Cell; 2022 Jul; 33(8):ar69. PubMed ID: 35511821
[TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association.
Perng MD; Wen SF; Gibbon T; Middeldorp J; Sluijs J; Hol EM; Quinlan RA
Mol Biol Cell; 2008 Oct; 19(10):4521-33. PubMed ID: 18685083
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation.
Yoshida T; Nakagawa M
Neuropathology; 2012 Aug; 32(4):440-6. PubMed ID: 22118268
[TBL] [Abstract][Full Text] [Related]
16. Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin.
Perng MD; Cairns L; van den IJssel P; Prescott A; Hutcheson AM; Quinlan RA
J Cell Sci; 1999 Jul; 112 ( Pt 13)():2099-112. PubMed ID: 10362540
[TBL] [Abstract][Full Text] [Related]
17. Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin.
Koyama Y; Goldman JE
Am J Pathol; 1999 May; 154(5):1563-72. PubMed ID: 10329608
[TBL] [Abstract][Full Text] [Related]
18. GFAP and its role in Alexander disease.
Quinlan RA; Brenner M; Goldman JE; Messing A
Exp Cell Res; 2007 Jun; 313(10):2077-87. PubMed ID: 17498694
[TBL] [Abstract][Full Text] [Related]
19. Redistribution of GFAP and alphaB-crystallin after thermal stress in C6 glioma cell line.
Tseng WC; Lu KS; Lee WC; Chien CL
J Biomed Sci; 2006 Sep; 13(5):681-94. PubMed ID: 16729237
[TBL] [Abstract][Full Text] [Related]
20. Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes.
Tian R; Wu X; Hagemann TL; Sosunov AA; Messing A; McKhann GM; Goldman JE
J Neuropathol Exp Neurol; 2010 Apr; 69(4):335-45. PubMed ID: 20448479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
